UroLift is a minimally invasive treatment option for benign prostatic hyperplasia (BPH), also called enlarged prostate.
Medicare covers the UroLift procedure when a doctor deems it medically necessary. If you undergo the procedure in an outpatient setting, Medicare Part B will cover it.
The amount that Medicare pays for a UroLift procedure varies based on where the procedure takes place. The medical name for the procedure is cystourethroscopy with insertion of transprostatic implant.
According to the Centers for Medicare & Medicaid Services (CMS), when the initial procedure takes place in a facility setting (like a hospital or ambulatory surgical center), physicians bill between $185 and $288.
When the initial procedure takes place in a non-facility setting (like a doctor’s office), physicians bill between $1,007 and $1,758, per CMS.
The procedure often involves adding multiple implants, which will cost more.
When Medicare Part B covers a UroLift procedure, you typically pay 20% of the procedure cost after reaching your deductible of $257 in 2025.
Additionally, Medicare reports that average out-of-pocket costs for the procedure are $752 at ambulatory surgical centers and $986 at hospital outpatient departments. These higher numbers reflect the addition of multiple implants.
The UroLift procedure is a treatment for BPH that involves a doctor accessing your prostate through the urethra. They’ll insert implants, which will pull away prostate tissue that is obstructing blood flow. You may receive local or general anesthetic during the procedure.
The surgery aims to relieve urinary and other symptoms related to enlarged prostate. The procedure preserves sexual function and typically doesn’t require a catheter during recovery.
It is best to speak with your physician and insurance provider for details about your coverage and costs.